Probiotic bacteria can diagnose, prevent, and treat infections

June 14, 2018 by Anne Trafton, Massachusetts Institute of Technology
Credit: Massachusetts Institute of Technology

MIT engineers have developed a probiotic mix of natural and engineered bacteria to diagnose and treat cholera, an intestinal infection that causes severe dehydration.

Cholera outbreaks are usually caused by , and infections can turn fatal if not treated. The most common treatment is rehydration, which must be done intravenously if the patient is extremely dehydrated. However, intravenous treatment is not always available to patients who need it, and the disease kills an estimated 95,000 people per year.

The MIT team's new probiotic mix could be consumed regularly as a preventative measure in regions where cholera is common, or used to treat people soon after occurs, says James Collins, the Termeer Professor of Medical Engineering and Science in MIT's Institute for Medical Engineering and Science (IMES) and Department of Biological Engineering.

"Our goal was to use synthetic biology to develop an inexpensive means to detect and diagnose as well as suppress or treat cholera infections," says Collins, who is the senior author of the study. "If one could inexpensively and quickly track the disease and treat it with natural or engineered probiotics, it could be a game-changer in many parts of the world."

The lead authors of the paper, which appears in the June 13 issue of Science Translational Medicine, are former Boston University graduate student Ning Mao, MIT postdoc Andres Cubillos-Ruiz, and former MIT postdoc D. Ewen Cameron.

Detection and treatment

To create their "living diagnostic" for cholera, the researchers chose a strain of bacteria called Lactococcus lactis, which is safe for human consumption and is used in the production of cheese and buttermilk.

They engineered into this bacterium a genetic circuit that detects a molecule produced by Vibrio cholerae, the microbe that causes cholera. When engineered L. lactis encounters this molecule, known as CAI-1, it sets off a signaling cascade that turns on an enzyme called beta-lactamase. This enzyme produces a red color that can be detected by analyzing stool samples. This process now takes several hours, but the researchers hope to shorten that time.

The researchers had hoped to further engineer L. lactis so that it could treat or prevent cholera infections. They began by engineering the microbes to produce antimicrobial peptides that could kill V. cholerae, but they eventually found that the peptides were being rendered harmless after being secreted by the cells.

Serendipitously, however, the team discovered that unmodified L. lactis can actually kill cholera microbes by producing , a natural byproduct of their metabolism. Lactic acid makes the gastrointestinal environment more acidic, inhibiting the growth of V. cholerae.

The engineered version of L. lactis does not produce enough lactic acid to kill cholera microbes, so the researchers combined the engineered bacteria with the unmodified version to create a probiotic mixture that can both detect and treat cholera. In tests in mice, the researchers found that this probiotic mixture could successfully prevent cholera infections from developing and could also treat existing infections.

Alternatives to antibiotics

Collins says he anticipates that the , which could be incorporated into a pill or a yogurt-like drink, could be used either as a preventative measure or for treating infections once they begin. Having the ability to diagnose cholera easily could also help public health officials detect outbreaks earlier and monitor the spread of the disease.

"I am particularly excited about this study because it presents a series of far-reaching, practical possibilities as well as scientific advances," says Matthew Chang, an associate professor of biochemistry at the National University of Singapore, who was not involved in the research.

"For instance, this work certainly enables us to envision the direct use of probiotics in combination with their modified forms for the surveillance and prevention of ," Chang says. "Even further, many can leverage this study, in particular its generalizable 'sense-and-respond' approach, to devise various diet-based prophylactic strategies against other communicable infectious diseases."

The MIT team is now exploring the possibility of using this approach to combat other microbes, such as Clostridium difficile, which causes gastrointestinal infections, and bacteria known as enterococci, which can cause many types of infections.

"There is emerging interest in using probiotics to treat disease, largely from the growing recognition of the microbiome and the role it plays in health and disease, and the pressing need to find alternatives to antibiotics," Collins says.

Explore further: Turning the tables on the cholera pathogen

More information: N. Mao el al., "Probiotic strains detect and suppress cholera in mice," Science Translational Medicine (2018). stm.sciencemag.org/lookup/doi/ … scitranslmed.aao2586

Related Stories

Turning the tables on the cholera pathogen

June 13, 2018

Recent cholera outbreaks in regions that are ravaged by war, struck by natural disasters, or simply lack basic sanitation, such as Yemen or Haiti, are making the development of new and more effective interventions a near-term ...

Fast-acting cholera vaccine could curb outbreaks

June 13, 2018

A tricked-out cholera vaccine starts protecting against the deadly disease within a day, experiments in rabbits suggest. The rapid protection offered by this designer vaccine may one day limit the spread of cholera outbreaks, ...

Running rings around cholera outbreaks

February 27, 2018

Targeting vaccine and other interventions to those in the vicinity of people with cholera could be an effective way to control cholera outbreaks, which can have devastating effects after disasters and in other emergency settings, ...

Cholera hotspots found at Uganda's borders and lakes

December 28, 2017

Uganda is among the countries is sub-Saharan Africa where cholera remains a recurring problem, despite advances in science and technology for prevention, detection and treatment of the infectious disease. Now, researchers ...

Recommended for you

Spotlighting differences in closely-related species

October 22, 2018

There are millions of fungal species, and those few hundred found in the Aspergillus genus play important roles in areas ranging from industrial production to agricultural plant pathogens. Reported October 22, 2018, in Nature ...

Cellular trash cans reveal the roles of proteins in disease

October 22, 2018

If we really want to know how our body's cells work—or don't work, in the case of disease—we might need to look beyond their genes and even beyond the proteins they are made of. We may need to start going through the ...

Cells that change jobs to fight diabetes

October 22, 2018

Diabetes is characterized by persistent high blood sugar levels that occur when certain cells in the pancreas—the insulin-producing β cells—are destroyed or are no longer able to secrete insulin. Researchers at the University ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

Gigel
not rated yet Jun 14, 2018
So why not treating sick people with an acidifier instead; i.e. capsules / gastric washes containing lactic acid or other acids? Or some acidic food.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.